Armata Pharmaceuticals Shares Rise on Additional $2.5M Government Grant

Dow Jones

Jun 23

By Katherine Hamilton

Shares of Armata Pharmaceuticals were higher after the company received an additional $2.5 million in funding from a Pentagon grant.

The stock gained 5% to $7.21 in premarket trading Tuesday. Through Monday's close, the stock was up 9% this year.

The late clinical-stage biotechnology company said the award now totals $28.7 million and is for the development of Armata's clinical candidate AP-SA02.

AP-SA02 is designed as an adjunct treatment of complicated Staphylococcus aureus bacteremia, or Staph infection.

The additional funding is intended to fund activities to support Phase 3 readiness of the treatment.

The money came through the Medical Technology Enterprise Consortium and is managed by the Naval Medical Research Command.

Write to Katherine Hamilton at katherine.hamilton@wsj.com

(END) Dow Jones Newswires

June 23, 2026 07:34 ET (11:34 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2645725833"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2645725833\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2645725833?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-23 19:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2645725833","market":"hk","top_or_hot":-1,"title":"Armata Pharmaceuticals Shares Rise on Additional $2.5M Government Grant","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine Hamilton \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Armata Pharmaceuticals were higher after the company received an additional $2.5 million in funding from a Pentagon grant. \n</p>\n<p>\n  The stock gained 5% to $7.21 in premarket trading Tuesday. Through Monday's close, the stock was up 9% this year. \n</p>\n<p>\n  The late clinical-stage biotechnology company said the award now totals $28.7 million and is for the development of Armata's clinical candidate AP-SA02. \n</p>\n<p>\n  AP-SA02 is designed as an adjunct treatment of complicated Staphylococcus aureus bacteremia, or Staph infection. \n</p>\n<p>\n  The additional funding is intended to fund activities to support Phase 3 readiness of the treatment. \n</p>\n<p>\n  The money came through the Medical Technology Enterprise Consortium and is managed by the Naval Medical Research Command. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 23, 2026 07:34 ET (11:34 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Armata Pharmaceuticals Shares Rise on Additional $2.5M Government Grant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nArmata Pharmaceuticals Shares Rise on Additional $2.5M Government Grant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-06-23 19:34</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Katherine Hamilton \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Armata Pharmaceuticals were higher after the company received an additional $2.5 million in funding from a Pentagon grant. \n</p>\n<p>\n  The stock gained 5% to $7.21 in premarket trading Tuesday. Through Monday's close, the stock was up 9% this year. \n</p>\n<p>\n  The late clinical-stage biotechnology company said the award now totals $28.7 million and is for the development of Armata's clinical candidate AP-SA02. \n</p>\n<p>\n  AP-SA02 is designed as an adjunct treatment of complicated Staphylococcus aureus bacteremia, or Staph infection. \n</p>\n<p>\n  The additional funding is intended to fund activities to support Phase 3 readiness of the treatment. \n</p>\n<p>\n  The money came through the Medical Technology Enterprise Consortium and is managed by the Naval Medical Research Command. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 23, 2026 07:34 ET (11:34 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2645725833","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2645725833","pubTimestamp":1782214440,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Armata Pharmaceuticals were higher after the company received an additional $2.5 million in funding from a Pentagon grant.The stock gained 5% to $7.21 in premarket trading Tuesday. Through Monday's close, the stock was up 9% this year.The late clinical-stage biotechnology company said the award now totals $28.7 million and is for the development of Armata's clinical candidate AP-SA02.AP-SA02 is designed as an adjunct treatment of complicated Staphylococcus aureus bacteremia, or Staph infection.The additional funding is intended to fund activities to support Phase 3 readiness of the treatment.The money came through the Medical Technology Enterprise Consortium and is managed by the Naval Medical Research Command.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","ARMP":"Armata Pharmaceuticals, Inc."},"translate_title":"Armata Pharmaceuticals股价因额外250万美元政府拨款而上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARMP":0.9},"content_text":"By Katherine Hamilton \n\n\n \n\n\n  Shares of Armata Pharmaceuticals were higher after the company received an additional $2.5 million in funding from a Pentagon grant. \n\n\n  The stock gained 5% to $7.21 in premarket trading Tuesday. Through Monday's close, the stock was up 9% this year. \n\n\n  The late clinical-stage biotechnology company said the award now totals $28.7 million and is for the development of Armata's clinical candidate AP-SA02. \n\n\n  AP-SA02 is designed as an adjunct treatment of complicated Staphylococcus aureus bacteremia, or Staph infection. \n\n\n  The additional funding is intended to fund activities to support Phase 3 readiness of the treatment. \n\n\n  The money came through the Medical Technology Enterprise Consortium and is managed by the Naval Medical Research Command. \n\n\n \n\n\n  Write to Katherine Hamilton at katherine.hamilton@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 23, 2026 07:34 ET (11:34 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}